These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6351421)

  • 21. [Practical interest of the determination of urinary fibrin degradation products in the early monitoring of kidney transplants].
    André E; Kessler M; Briquel ME; Alexandre P; Hurault de Ligny B; Huriet C
    Pathol Biol (Paris); 1983 Jan; 31(1):23-7. PubMed ID: 6343962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of hemocoagulation in acute clinical rejection of kidney allograft. Clinical and therapeutical investigations in 48 patients.
    Cortellaro M; Pogliani E; Rossi E; Maioli M; Ponticelli C; Vallino F; Politi A; Polli EE
    Haematologica; 1975 Dec; 60(4):446-65. PubMed ID: 816715
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 25. Daily immunologic tests in the prediction of renal transplant rejection.
    Wood RF; Gray AC; Bell PR
    Transplant Proc; 1978 Sep; 10(3):593-4. PubMed ID: 362640
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of urinary N-acetyl-beta-D-glucosaminidase and urinary fibrin degradation products for diagnosis of rejection after renal transplantation.
    Corbett R; Gardner GJ; Kind PR; Thompson AE; Price RG
    Clin Chim Acta; 1983 Feb; 128(1):141-50. PubMed ID: 6340858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary fibrin/fibrinogen degradation products (FDP) in chronic glomerulonephritis].
    Shimamatsu K
    Fukuoka Igaku Zasshi; 1986 Sep; 77(9):480-9. PubMed ID: 3804170
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
    Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
    Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Qualitative analysis of urinary fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T
    Nihon Hinyokika Gakkai Zasshi; 1978 Nov; 69(11):1391-403. PubMed ID: 368396
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibrinogen degradation products in acute renal failure of the newborn.
    Assadi F; Delivoria-Papadopoulos M; Pereira G; Peckham G; Norman M
    Clin Nephrol; 1983 Feb; 19(2):74-81. PubMed ID: 6839555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urinary and serum fibrin/fibrinogen degradation products in renal transplant rejection (author's transl)].
    Akiyama T; Kaneko S; Iguchi M; Minami K; Kadowaki T
    Nihon Hinyokika Gakkai Zasshi; 1977 Jun; 68(6):599-608. PubMed ID: 335137
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary fibrin (-ogen) degradation products in Russell's viper (Daboia russelii siamensis) bite victims.
    Han KE; Than T; Lwin M; Swe TN; Pe T
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):198-201. PubMed ID: 8362297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of fibrin (fibrinogen) degradation products in urine].
    Andreenko GV; Podorol'skaia LV
    Lab Delo; 1983; (4):35-8. PubMed ID: 6191081
    [No Abstract]   [Full Text] [Related]  

  • 37. [Urinary FDP D-dimer and E fragments in renal transplantation].
    Akiyama T; Ikegami M; Imanishi M; Ishii T; Nishioka T; Uemura T; Kunikata S; Mitsubayashi S; Kanda H; Matsuura T
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1680-5. PubMed ID: 2287115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
    Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urinary FDP].
    Hashimoto S; Sawa H
    Rinsho Byori; 1983 May; 31(5):480-8. PubMed ID: 6632306
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dynamics of the immunological and blood coagulation indices in experimental kidney allotransplantation].
    Drannik GN
    Urol Nefrol (Mosk); 1978; (2):48-51. PubMed ID: 347665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.